Literature DB >> 8024248

Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis.

T Z Baram1, I Gonzalez-Gomez, Z D Xie, D Yao, F H Gilles, M D Nelson, H T Nguyen, J Peters.   

Abstract

Subacute sclerosing panencephalitis (SSPE) is related to "defective" measles virus or vaccination, though an association with parainfluenza viruses has been reported. SSPE is characterized by a slow, erratic course and elevated cerebrospinal fluid measles titers. An immunocompetent, vaccinated infant, with onset of symptoms in parainfluenza virus season and a catastrophic course is described. Cerebrospinal fluid titers were negative, but postmortem brain had typical SSPE lesions. Patient brain-derived RNA, subjected to reverse transcription followed by polymerase chain reaction yielded polymerase chain reaction products with measles virus but not parainfluenza virus genes. The sequenced fragment revealed multiple mutations, typical for SSPE. SSPE can thus present in infants, with short latency and no cerebrospinal fluid antibodies. Viral genomic analysis may be diagnostic, permitting early therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024248      PMCID: PMC3794670          DOI: 10.1002/ana.410360120

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  15 in total

1.  Detection of measles virus genomic sequences in SSPE brain tissue by the polymerase chain reaction.

Authors:  M S Godec; D M Asher; P T Swoveland; Z A Eldadah; S M Feinstone; L G Goldfarb; C J Gibbs; D C Gajdusek
Journal:  J Med Virol       Date:  1990-04       Impact factor: 2.327

2.  Interferon in treatment of subacute sclerosing panencephalitis.

Authors:  P O Behan
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

3.  Different virus antibodies in serum and cerebrospinal fluid of patients suffering from subacute sclerosing panencephalitis.

Authors:  A M Abdelnoor; S S Dhib-Jalbut; F S Haddad
Journal:  J Neuroimmunol       Date:  1982-01       Impact factor: 3.478

4.  [Parainfluenzal encephalitis with predominant clinical symptoms of status epilepticus].

Authors:  M Wender
Journal:  Pediatr Pol       Date:  1980-02

5.  Experimental panencephalitis induced in suckling mice by parainfluenza type 1 (6/94) virus. I. Clinical and pathological features.

Authors:  L B Rorke; K H Gilden; Z Wroblewska; J S Wolinsky
Journal:  J Neuropathol Exp Neurol       Date:  1976-05       Impact factor: 3.685

6.  The variable natural history of subacute sclerosing panencephalitis: a study of 118 cases from the Middle East.

Authors:  W S Risk; F S Haddad
Journal:  Arch Neurol       Date:  1979-10

7.  Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis.

Authors:  K Yalaz; B Anlar; F Oktem; S Aysun; S Ustacelebi; O Gurcay; K Gucuyener; Y Renda
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

8.  Neurological diseases associated with viral and Mycoplasma pneumoniae infections.

Authors:  F Assaad; R Gispen; M Kleemola; L Syrůcek; K Esteves
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

9.  Changing character of subacute sclerosing panencephalitis in the United States.

Authors:  P R Dyken; S C Cunningham; L C Ward
Journal:  Pediatr Neurol       Date:  1989 Nov-Dec       Impact factor: 3.372

10.  Biased hypermutation and other genetic changes in defective measles viruses in human brain infections.

Authors:  R Cattaneo; A Schmid; D Eschle; K Baczko; V ter Meulen; M A Billeter
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

View more
  2 in total

1.  Subacute sclerosing panencephalitis : diagnosis and drug treatment options.

Authors:  B Anlar
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 2.  Viral Infections of the Central Nervous System in Children: A Systematic Review.

Authors:  Abba Musa Abdullahi; Shah T Sarmast; Nusrat Jahan
Journal:  Cureus       Date:  2020-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.